Zhong Wang: Clinical Trials

12 trials sponsored by Zhong Wang, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 unknown, 3 completed, 2 suspended. 4 Early Phase 1, 2 Phase 4, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Early Phase 14Completed 2, Unknown 2
Phase 42Unknown 2
Phase 21Suspended 1
Phase 31Suspended 1

Follow Zhong Wang: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Post-marketing Safety and Efficacy Surveillance of Motherwort Injection
Motherwort injection - Bleeding, Real-world Study
UnknownZhong Wang200002024-10-152024-10-15
Yinhu Qingwen Granule in the Treatment of Viral Pneumonia
Yinhu Qingwen Granules - Viral Pneumonia
Early Phase 1UnknownZhong Wang602022-12-012022-11-15
Yinhu Qingwen Granula for the Treatment of Severe CoVID-19
Yinhu Qingwen Granula, Yin Hu Qing Wen Granula(low does), standard medical treatment - COVID-19, Severe Pneumonia
Phase 2 / Phase 3SuspendedZhong Wang1162021-11-012021-07-07
Effect of Zhuli Capsule on Phlegm-heat Syndrome (Tan-re Zheng)
Zhuli capsule, Placebo, Standard medical treatment - Chronic Obstructive Pulmonary Disease, Chronic Bronchitis
Phase 4UnknownZhong Wang3242021-07-012021-06-15
Qingfei Granule for the Treatment of the Pediatric Acute Upper Respiratory Tract Infection With Bacterial Infection
QingFei Granule, Cefuroxime - Upper Respiratory Tract Infection, Bacterial Infection
Early Phase 1UnknownZhong Wang602020-10-172022-11-15
Post-marketing Safety Surveillance of Qizhi Tongluo Capsules:a Registry Study.
Qizhi Tongluo Capsules - Safety Surveillance, Adverse Drug Events
UnknownZhong Wang300002020-08-172022-11-15
Xuefu-Zhuyu Capsule for the Treatment of "Qizhi Xueyu Zheng" (Qi Stagnation and Blood Stasis Syndrome)
Xuefu-Zhuyu Capsule, placebo, conventional therapy - Chinese Medicine, Stable Coronary Heart Disease
Phase 4UnknownZhong Wang7202019-12-312022-11-15
Jiu-wei-zhen-xiao Granule for Advanced Hepatocellular Carcinoma
Jiu-wei-zhen-xiao Granule - Hepatocellular Carcinoma
Early Phase 1CompletedZhong Wang102019-04-072021-04-09
Post-marketing Safety Surveillance of Xueshuantong-Injection : a Registry Study
Xueshuantong-Injection - Adverse Drug Event, Adverse Drug Reactions
UnknownZhong Wang300002019-02-182021-07-07
Danshen-Jiang-Fu Granule Prepared by Danshen From Different Producing Areas for Primary Dysmenorrhea
Shandong Danshen-Jiang-Fu Granule, Sichuan Danshen-Jiang-Fu Granule - Primary Dysmenorrhea, Traditional Chinese Medicine
Early Phase 1CompletedZhong Wang912015-11-012019-02-05
Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study
Breviscapine Powder-Injection - Adverse Drug Event, Adverse Drug Reaction
SuspendedZhong Wang200002015-09-012021-04-08
Post-marketing Safety Surveillance of Compound Kuh-seng Injection: a Registry Study
Compound Kuh-seng Injection - Safety Surveillance, Adverse Drug Events
CompletedZhong Wang302832014-09-012018-10-10

Conditions studied

Drug-Related Side Effects and Adverse Reactions (4)  ·  Anaphylaxis (2)  ·  Bacterial Infections (1)  ·  Bronchitis, Chronic (1)  ·  COVID-19 (1)  ·  Carcinoma, Hepatocellular (1)  ·  Endometriosis (1)  ·  Headache (1)  ·  Hemorrhage (1)  ·  Pneumonia (1)  ·  Pneumonia, Viral (1)  ·  Pulmonary Disease, Chronic Obstructive (1)  ·  Respiratory Tract Infections (1)  ·  Sleep Initiation and Maintenance Disorders (1)

Interventions

Cefuroxime (1)  ·  Xue-Fu-Zhu-Yu decoction (1)

Countries

China (11)

Top investigators

Dong Shang, M.D. (1)  ·  Jiang-Rong Huang, M.D. (1)  ·  Jinmin Liu, M.D. (1)  ·  Qing-Quan Liu, Prof. (1)  ·  Xiao-Dong Li, M.D. (1)  ·  Xin-zhi Wang (1)  ·  Zhan-Yu Pan, Ph.D. (1)